there appears to be zero chance of the oppies getting into the money in coming weeks. the way the company has overshot so many deadlines and the extreme length of time taken to get this far, suggests the product might not be all that flash.
someone had to pay for the ride and i wonder who that would have been.
i'm not an expert in this particular field but if the product was as good as shareholders believe it be, why has the company been fumbling with its development for the best part of a decade.
the timeline for the phase three trial this year looks comic in retrospect, partic after all those years in product development.
a joke that as an oppie holder was on me
GLTA and i hope that the holders of the heads get an opportunity to take a profit, which of course has been denied to the oppie holders.
EMS Price at posting:
3.0¢ Sentiment: ST Sell Disclosure: Held
